BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11763018)

  • 1. Differences between in vitro and in vivo determinations of fluvoxamine-clozapine interaction.
    Lu ML; Lane HY; Chang WH
    J Clin Psychopharmacol; 2001 Dec; 21(6):625-6. PubMed ID: 11763018
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine-clozapine interaction: time-dependent?
    Lu ML; Lane HY; Chang WH
    J Clin Psychopharmacol; 2002 Aug; 22(4):439-40. PubMed ID: 12172350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clozapine and selective serotonin reuptake inhibitors: risks of toxicity].
    Michielsen PJ; Thunnissen MM; Van Den Bossche B
    Tijdschr Psychiatr; 2007; 49(9):655-9. PubMed ID: 17853375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of sertraline with clozapine.
    Pinninti NR; de Leon J
    J Clin Psychopharmacol; 1997 Apr; 17(2):119-20. PubMed ID: 10950477
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serious drug interaction between clozapine-Leponex and fluvoxamine-Fevarin].
    Olesen OV; Starup G; Linnet K
    Ugeskr Laeger; 1996 Nov; 158(48):6931-2. PubMed ID: 8984760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine-Clozapine drug interaction: inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism.
    Olesen OV; Linnet K
    J Clin Psychopharmacol; 2000 Feb; 20(1):35-42. PubMed ID: 10653206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments on in vitro and in vivo studies of fluvoxamine-clozapine interaction.
    Olesen OV; Linnet K
    J Clin Psychopharmacol; 2002 Oct; 22(5):527-8. PubMed ID: 12352280
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated plasma levels of clozapine after concomitant use of fluvoxamine.
    Heeringa M; Beurskens R; Schouten W; Verduijn MM
    Pharm World Sci; 1999 Oct; 21(5):243-4. PubMed ID: 10550852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment.
    Chertkow Y; Weinreb O; Youdim MB; Silver H
    J Neural Transm (Vienna); 2007; 114(11):1443-54. PubMed ID: 17576515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine.
    Azuma J; Hasunuma T; Kubo M; Miyatake M; Koue T; Higashi K; Fujiwara T; Kitahara S; Katano T; Hara S
    Eur J Clin Pharmacol; 2012 Jan; 68(1):29-37. PubMed ID: 21739267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reaction on 'Addition of fluvoxamine to clozapine: theory and practice'].
    Sommer I
    Tijdschr Psychiatr; 2013; 55(4):309-10. PubMed ID: 23595848
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
    Sproule BA; Naranjo CA; Brenmer KE; Hassan PC
    Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reaction on 'Addition of fluvoxamine to clozapine: theory and practice'. Reply to Sommer].
    Wigard M; Van Gool A; Schulte PF
    Tijdschr Psychiatr; 2013; 55(4):310-2. PubMed ID: 23678524
    [No Abstract]   [Full Text] [Related]  

  • 14. [Addition of fluvoxamine to clozapine: theory and practice].
    Wigard ME; van Gool AR; Schulte PF
    Tijdschr Psychiatr; 2013; 55(2):113-21. PubMed ID: 23408363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine increases plasma and urinary levels of clozapine and its major metabolites in a time- and dose-dependent manner.
    Fabrazzo M; La Pia S; Monteleone P; Mennella R; Esposito G; Pinto A; Maj M
    J Clin Psychopharmacol; 2000 Dec; 20(6):708-10. PubMed ID: 11106150
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
    Wetzel H; Anghelescu I; Szegedi A; Wiesner J; Weigmann H; Härter S; Hiemke C
    J Clin Psychopharmacol; 1998 Feb; 18(1):2-9. PubMed ID: 9472836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine.
    Chang WH; Augustin B; Lane HY; ZumBrunnen T; Liu HC; Kazmi Y; Jann MW
    Psychopharmacology (Berl); 1999 Jul; 145(1):91-8. PubMed ID: 10445377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances.
    Lu ML; Lane HY; Lin SK; Chen KP; Chang WH
    J Clin Psychiatry; 2004 Jun; 65(6):766-71. PubMed ID: 15291653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood clozapine levels elevated by fluvoxamine: potential for side effects and lower clozapine dosage.
    Armstrong SC; Stephans JR
    J Clin Psychiatry; 1997 Nov; 58(11):499. PubMed ID: 9413421
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2.
    Brøsen K
    Clin Pharmacokinet; 1995; 29 Suppl 1():20-5. PubMed ID: 8846619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.